AUGUSTA, Ga. – No one could blame Max Homa if last year’s T-3 finish at the Masters feels like decades ago. Homa arrives at Augusta National this week with a decidedly different look – new clubs ...

Researchers found most samples resistant to key antibiotics, including carbapenems, with 97% carrying plasmids that spread resistance, highlighting the urgent need for global surveillance and ...

baumannii were resistant to multiple antibiotics, with most resistant to carbapenems - the drugs of choice for the treatment of A. baumannii infections. The findings come after an investigation of ...

Researchers believe they have identified a new class of antibiotics, nearly three decades ... it has the potential to be a durable and lasting choice for a large variety of deadly bacterial ...

Prescription antibiotics, such as penicillin, have helped people to recover from otherwise fatal diseases and conditions since the 1940s. However, many people may consider alternative treatments ...

Lariocidin hits drug-resistant bacteria where others fail — by hijacking the ribosome at a new site, bypassing defences, and opening the door to a new generation of antibiotics. Lariocidin ...

diff to infect the superbug, which is known to rapidly evolve resistance to antibiotics. The friendly viruses, known as bacteriophages (phages), are viruses that selectively target and kill their ...

A GSK pill that offers a lower potential for drug resistance is now FDA approved as a new treatment for a common type of urinary tract infection, the first new oral antibiotic for this indication ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

The treatment was popularised in the early 20th century, but the mass production of antibiotics led to its demise in Western medicine. With antimicrobial resistance a major global health threat ...

A new antibiotic has been approved to treat urinary tract infections by the Food and Drug Administration for the first time in decades. It’s an oral pill called Blujepa from the London-based biopharma ...